OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of indigenous microbes on Parkinson's disease
Timothy R. Sampson
Neurobiology of Disease (2019) Vol. 135, pp. 104426-104426
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice
Timothy R. Sampson, Collin Challis, Neha Jain, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 338

The future of stem cell therapies for Parkinson disease
Malin Parmar, Shane Grealish, Claire Henchcliffe
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 2, pp. 103-115
Closed Access | Times Cited: 258

An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants
Deborah A. Hall, Robin M. Voigt, Thaisa M. Cantu-Jungles, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57

Diet in Parkinson's Disease: Critical Role for the Microbiome
Aeja Jackson, Christopher B. Forsyth, Maliha Shaikh, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 107

The gut microbiome in Parkinson's disease: A culprit or a bystander?
Ali Keshavarzian, Phillip A. Engen, Salvatore Bonvegna, et al.
Progress in brain research (2020), pp. 357-450
Closed Access | Times Cited: 85

The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance
Elisa Menozzi, Jane Macnaughtan, Anthony H.V. Schapira
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 611-625
Open Access | Times Cited: 63

Gut–Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization
Bruno Tilocca, Luisa Pieroni, Alessio Soggiù, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4045-4045
Open Access | Times Cited: 60

Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition
Maja Milošević, Aleksandra Arsić, Zorica Cvetković, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 49

Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease
Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, et al.
International Journal of Pharmaceutics X (2021) Vol. 3, pp. 100087-100087
Open Access | Times Cited: 46

Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria
A. Raquel Esteves, Mario Muñoz, Daniela Nunes‐Costa, et al.
Gut (2021) Vol. 72, Iss. 1, pp. 73-89
Open Access | Times Cited: 46

Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
Gagandeep Kaur, Tapan Behl, Simona Bungău, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 233-247
Open Access | Times Cited: 46

Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
Sebastiaan P. van Kessel, Sahar El Aidy
Journal of Parkinson s Disease (2019) Vol. 9, Iss. s2, pp. S359-S370
Open Access | Times Cited: 45

Influence of nutrition and epigenetics on the development of neurodegenerative diseases in elderly and old people
С. В. Булгакова, D. P. Kurmaev, E. V. Treneva, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 8, pp. 89-95
Closed Access

Feature Selection Based Twin-Support Vector Machine for the Diagnosis of Parkinson’s Disease
Surendrabikram Thapa, Surabhi Adhikari, Awishkar Ghimire, et al.
(2020)
Closed Access | Times Cited: 34

The oropharyngeal microbiome is altered in individuals with schizophrenia and mania
Robert H. Yolken, Emese Prandovszky, Emily G. Severance, et al.
Schizophrenia Research (2020) Vol. 234, pp. 51-57
Closed Access | Times Cited: 33

Gut-first Parkinson’s disease is encoded by gut dysbiome
Mario Muñoz, Emanuel Candeias, Inês Melo-Marques, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4

Dysbiosis in Parkinson’s disease might be triggered by certain antibiotics
Gábor Ternák, Dániel Kuti, Krisztina Kovács
Medical Hypotheses (2020) Vol. 137, pp. 109564-109564
Open Access | Times Cited: 31

T cells, α-synuclein and Parkinson disease
Francesca Garretti, Connor Monahan, Alessandro Sette, et al.
Handbook of clinical neurology (2022), pp. 439-455
Open Access | Times Cited: 17

Helicobacter hepaticus augmentation triggers Dopaminergic degeneration and motor disorders in mice with Parkinson’s disease
Eun Hee Ahn, Xia Liu, Ashfaqul Alam, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1337-1350
Closed Access | Times Cited: 14

Ruminal Microbes Exhibit a Robust Circadian Rhythm and Are Sensitive to Melatonin
Jialiang Ouyang, Mengzhi Wang, Dengpan Bu, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 19

Parkinson's disease and the gut: Models of an emerging relationship
Adam J. Bindas, Subhash Kulkarni, Ryan A. Koppes, et al.
Acta Biomaterialia (2021) Vol. 132, pp. 325-344
Closed Access | Times Cited: 18

Disease mechanisms as subtypes: Microbiome
Salvatore Bonvegna, Roberto Cilia
Handbook of clinical neurology (2023), pp. 107-131
Closed Access | Times Cited: 7

Gut dysfunction may be the source of pathological aggregation of alpha-synuclein in the central nervous system through Paraquat exposure in mice
Kaidong Wang, Chunhui Zhang, Baofu Zhang, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 246, pp. 114152-114152
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top